Digital Transformation Opportunities Corp., a blank check company, intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses or entities. The company was founded in 2020 and is based in Bellevue, Washington.
IPO Year: 2021
Exchange: NASDAQ
Website: dtocorp.com
Date | Price Target | Rating | Analyst |
---|
FORT MYERS, Fla. and LOS ANGELES, Sept. 20, 2023 (GLOBE NEWSWIRE) -- American Oncology Network, LLC ("AON" or the "Company"), a rapidly growing network of community-based oncology practices, and Digital Transformation Opportunities Corp. (NASDAQ:DTOC) ("DTOC"), a special purpose acquisition company focused on the healthcare industry, announced today the completion of their previously announced business combination (the "Business Combination"). The combined company has been renamed American Oncology Network, Inc., and its common stock is expected to commence trading on the Nasdaq Stock Market LLC ("Nasdaq") under the new ticker symbol "AONC" on September 21, 2023. The Business Combination
TORONTO, Jan. 11, 2023 /CNW/ - D2L Inc. (TSX:DTOL) ("D2L" or the "Company"), a leading global learning technology company, today announced the appointment of technology executive Heather Zynczak to its Board of Directors. Zynczak spent the past 25 years in marketing, product and revenue leadership positions in technology. She was most recently Chief Marketing Officer of Pluralsight (NASDAQ:PS), where she was responsible for all aspects of marketing and digital revenue. During her tenure at Pluralsight, the company grew B2B revenue over 50% year-over-year, expanding revenue to
American Oncology Network (AON) is a rapidly growing network of community-based oncology practices The proposed transaction values the combined company at a pro forma enterprise value of approximately $500 million American Oncology Network ("AON" or the "Company"), a rapidly growing network of community-based oncology practices, and Digital Transformation Opportunities Corp. (NASDAQ:DTOC) ("DTOC"), a special purpose acquisition company focused on the healthcare industry, today announced that they have entered into a definitive business combination agreement pursuant to which AON will become a public company (the "Business Combination"). Upon completion of the Business Combination, the
TORONTO, Jan. 11, 2023 /CNW/ - D2L Inc. (TSX:DTOL) ("D2L" or the "Company"), a leading global learning technology company, today announced the appointment of technology executive Heather Zynczak to its Board of Directors. Zynczak spent the past 25 years in marketing, product and revenue leadership positions in technology. She was most recently Chief Marketing Officer of Pluralsight (NASDAQ:PS), where she was responsible for all aspects of marketing and digital revenue. During her tenure at Pluralsight, the company grew B2B revenue over 50% year-over-year, expanding revenue to
SC 13D - American Oncology Network, Inc. (0001839998) (Subject)
SC 13D/A - American Oncology Network, Inc. (0001839998) (Subject)
SC 13D - American Oncology Network, Inc. (0001839998) (Subject)
SC 13G/A - Digital Transformation Opportunities Corp. (0001839998) (Subject)
SC 13G - Digital Transformation Opportunities Corp. (0001839998) (Subject)
4/A - American Oncology Network, Inc. (0001839998) (Issuer)
3/A - American Oncology Network, Inc. (0001839998) (Issuer)
4 - American Oncology Network, Inc. (0001839998) (Issuer)
4/A - American Oncology Network, Inc. (0001839998) (Issuer)
4 - American Oncology Network, Inc. (0001839998) (Reporting)
3 - American Oncology Network, Inc. (0001839998) (Issuer)
4/A - American Oncology Network, Inc. (0001839998) (Issuer)
4 - American Oncology Network, Inc. (0001839998) (Issuer)
4 - American Oncology Network, Inc. (0001839998) (Issuer)
3 - American Oncology Network, Inc. (0001839998) (Issuer)
424B5 - American Oncology Network, Inc. (0001839998) (Filer)
EFFECT - American Oncology Network, Inc. (0001839998) (Filer)
S-8 - American Oncology Network, Inc. (0001839998) (Filer)
8-K - American Oncology Network, Inc. (0001839998) (Filer)
S-1/A - American Oncology Network, Inc. (0001839998) (Filer)
8-K - American Oncology Network, Inc. (0001839998) (Filer)
S-1 - American Oncology Network, Inc. (0001839998) (Filer)
8-K - American Oncology Network, Inc. (0001839998) (Filer)
8-K - American Oncology Network, Inc. (0001839998) (Filer)
D - American Oncology Network, Inc. (0001839998) (Filer)
American Oncology Network, LLC ("AON" or the "Company"), a rapidly growing network of community-based oncology practices, and Digital Transformation Opportunities Corp. (NASDAQ:DTOC) ("DTOC"), a special purpose acquisition company focused on the healthcare industry, announced today the completion of their previously announced business combination (the "Business Combination"). The combined company has been renamed American Oncology Network, Inc., and its common stock is expected to commence trading on the Nasdaq Stock Market LLC ("Nasdaq") under the new ticker symbol "AONC" on September 21, 2023. The Business Combination was approved at a special meeting of DTOC's stockholders on September 19
Gainers MSP Recovery, Inc. (NASDAQ:LIFW) shares jumped 104.5% to $0.1916. Digital Transformation Opportunities Corp. (NASDAQ:DTOC) rose 100.7% to $27.50 after dipping 53% on Tuesday. Bluejay Diagnostics, Inc. (NASDAQ:BJDX) gained 56.4% to $4.8499. Bluejay Diagnostics, last month, announced a $1.59 million registered direct offering of 216,000 shares at $7.365 per share. Fresh Tracks Therapeutics, Inc. (NASDAQ:FRTX) shares gained 50% to $0.8705 after the company announced its Board of Directors has approved a plan of liquidation and dissolution. AgriFORCE Growing Systems Ltd. (NASDAQ:AGRI) rose 38% to $0.1478. TransCode Therapeutics, Inc. (NASDAQ:RNAZ) shares gained 32.9% to $0.6974
Gainers TransCode Therapeutics, Inc. (NASDAQ:RNAZ) shares rose 70.2% to $0.8937 in pre-market trading after falling 10% on Tuesday. Fresh Tracks Therapeutics, Inc. (NASDAQ:FRTX) shares rose 53.2% to $0.8887 in pre-market trading after the company announced its Board of Directors has approved a plan of liquidation and dissolution. EBET, Inc. (NASDAQ:EBET) shares rose 32.7% to $0.0702 in pre-market trading. Exscientia plc (NASDAQ:EXAI) shares jumped 25.6% to $6.36 in pre-market trading. Exscientia and Merck announced collaboration on AI-driven drug discovery in oncology, neuroinflammation, and immunology. Histogen Inc. (NASDAQ:HSTO) shares gained 21.5% to $0.48 in pre-market trading.
Gainers Connexa Sports Technologies Inc. (NASDAQ:CNXA) shares jumped 124.2% to $0.1697 after falling 15% on Monday. Avinger, Inc. (NASDAQ:AVGR) gained 63.9% to $9.95, adding to outsized gains from Monday. On Monday, Avinger shares soared 46.8% after the company announced the commercial launch of its Tigereye ST image-guided CTO crossing device. Sezzle Inc. (NASDAQ:SEZL) shares climbed 46.6% to $18.95. PHAXIAM Therapeutics S.A. (NASDAQ:PHXM) rose 30% to $5.17. Elutia Inc. (NASDAQ:ELUT) shares gained 29.1% to $1.6006 after the company announced the sale of its Orthobiologics business unit to Berkeley Biologics LLC. Elutia announced $26 million private placement of 7,355,869 shares of co
U.S. stocks traded lower this morning, with the Dow Jones falling around 40 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.12% to 34,581.70 while the NASDAQ fell 0.33% to 13,665.29. The S&P 500 also fell, dropping, 0.15% to 4,446.78. Check This Out: Dell Technologies To Rally More Than 15%? Here Are 10 Other Analyst Forecasts For Tuesday Leading and Lagging Sectors Energy shares rose by 0.4% on Tuesday. In trading on Tuesday, consumer discretionary shares fell by 1%. Top Headline Housing starts in the U.S. fell 11.3% month-over-month to an annualized rate of 1.283 million in August, recording the lowest level since June 2020. Equities Trading UP C